Dr Paula Wells oncology training was undertaken at St. Bartholomew's, UCLH and Mount Vernon Hospitals; following her Fellowship, she undertook a postgraduate research degree at Imperial College School of Medicine, Hammersmith Hospital. There she investigated the potential for Positron Emission Tomography to demonstrate the biological effects of chemotherapy in tissue. She has published a number of papers in this area and was awarded a PhD for her work. Subsequently, she completed her post-doctoral training at the Royal Marsden Hospital, principally with the Academic Urology Unit.
Dr Wells specializes in the management of patients with genitourinary (bladder and prostate) and thoracic (lung and mesothelioma) malignancies.
Since taking up her present post she has been extensively involved with the development of the genitourinary and thoracic cancer services for the North East London Cancer Network.
She is an active participant in UK clinical trials and is the principal investigator for the North East London Cancer Network for ten active studies. From these activities, she has been involved with the development of Intensity Modulated Radiotherapy for treatment of prostate cancer, and chemo-radiation in bladder and lung cancer for the Trust. Her research interest in Positron Emission Tomography continues to develop with an emphasis on investigating the direct effects of radiotherapy on tissue and the effect of integration of novel therapies with radiation.